27498145|t|Early effects of Abeta1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways.
27498145|a|Neuronal and synaptic loss are the best pathological correlates for memory decline in Alzheimer's disease (AD). Soluble beta-amyloid oligomers (AbetaO) are considered to putatively play a crucial role in the early synapse loss and cognitive impairment observed in AD. Evidence suggests that oxidative stress and apoptosis are involved in the mechanism of Abeta-induced neurotoxicity and AD pathogenesis. This study aimed to explore the molecular mechanisms that contribute to the early memory deficits induced by intracerebroventricular injection of AbetaO in mice. Ten days after a single AbetaO injection memory impairments were observed, as measured by Morris water maze and novel object recognition tests. Cognitive decline was associated with increased oxidative stress, caspase-9 activation, and decreased hippocampal synaptophysin immunoreactivity. Furthermore, GSH levels were significantly higher in AbetaO-injected mice than in sham mice, showing that a protective mechanism might develop due to oxidative stress. Additionally, AbetaO-induced toxicity was aligned with an increment of the activation of Akt and ERK1/2, and reduced activity of GSK3. These findings suggest that AbetaO injection triggers a cascade of events that mimic the key neuropathological hallmarks of AD. Abeta acute injection helps to better understand how this peptide impairs specific signaling pathways leading to synaptic and memory dysfunctions. Thus, this model is a valid tool for investigating AD and may suggest a new way to develop neuroprotective therapies at such early stages of the disease.
27498145	50	54	mice	Species	10090
27498145	76	79	Akt	Gene	11651
27498145	80	84	GSK3	Gene	56637
27498145	94	100	ERK1/2	Gene	26417;26413
27498145	111	137	Neuronal and synaptic loss	Disease	MESH:D012183
27498145	179	193	memory decline	Disease	MESH:D060825
27498145	197	216	Alzheimer's disease	Disease	MESH:D000544
27498145	218	220	AD	Disease	MESH:D000544
27498145	255	261	AbetaO	Gene	80908
27498145	325	337	synapse loss	Disease	MESH:D016388
27498145	342	362	cognitive impairment	Disease	MESH:D003072
27498145	375	377	AD	Disease	MESH:D000544
27498145	466	471	Abeta	Gene	11820
27498145	480	493	neurotoxicity	Disease	MESH:D020258
27498145	498	500	AD	Disease	MESH:D000544
27498145	597	612	memory deficits	Disease	MESH:D008569
27498145	661	667	AbetaO	Gene	80908
27498145	671	675	mice	Species	10090
27498145	701	707	AbetaO	Gene	80908
27498145	718	736	memory impairments	Disease	MESH:D008569
27498145	821	838	Cognitive decline	Disease	MESH:D003072
27498145	887	896	caspase-9	Gene	12371
27498145	935	948	synaptophysin	Gene	20977
27498145	980	983	GSH	Chemical	MESH:D005978
27498145	1020	1026	AbetaO	Gene	80908
27498145	1036	1040	mice	Species	10090
27498145	1054	1058	mice	Species	10090
27498145	1149	1155	AbetaO	Gene	80908
27498145	1164	1172	toxicity	Disease	MESH:D064420
27498145	1224	1227	Akt	Gene	11651
27498145	1232	1238	ERK1/2	Gene	26417;26413
27498145	1264	1268	GSK3	Gene	56637
27498145	1298	1304	AbetaO	Gene	80908
27498145	1394	1396	AD	Disease	MESH:D000544
27498145	1398	1403	Abeta	Gene	11820
27498145	1511	1543	synaptic and memory dysfunctions	Disease	MESH:D008569
27498145	1596	1598	AD	Disease	MESH:D000544
27498145	Negative_Correlation	56637	80908
27498145	Positive_Correlation	MESH:D005978	80908
27498145	Association	26417	80908
27498145	Association	11651	80908
27498145	Association	MESH:D064420	11651
27498145	Positive_Correlation	MESH:D003072	12371
27498145	Association	MESH:D064420	56637
27498145	Association	MESH:D064420	26417
27498145	Association	MESH:D003072	80908
27498145	Association	MESH:D008569	11820
27498145	Association	MESH:D020258	11820
27498145	Positive_Correlation	MESH:D008569	80908
27498145	Positive_Correlation	MESH:D064420	80908
27498145	Association	26413	80908
27498145	Positive_Correlation	MESH:D016388	80908
27498145	Association	MESH:D000544	80908
27498145	Association	MESH:D064420	26413
27498145	Association	MESH:D003072	20977

